Understanding the genetic contribution to rheumatoid arthritis

Current Opinion in Rheumatology

Volumn 17, Issue 3, 2005, Pages 299-304

  Van Der Helm van Mil, Annette H M ^a   Wesoly, Joanna Z ^a   Huizinga, Tom W J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Rheumatoid arthritis; Signal transduction pathway; T cell receptor

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; HLA A2 ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR RUNX1;

ALLELE; AUTOIMMUNE DISEASE; BINDING SITE; DIABETES MELLITUS; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG TARGETING; GENE; GENE INTERACTION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; PREVALENCE; PRIORITY JOURNAL; PTPN22 GENE; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SIGNAL TRANSDUCTION; SLC22A4 GENE; T LYMPHOCYTE ACTIVATION;

ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; VARIATION (GENETICS);

EID: 18144362054     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000160780.13012.be     Document Type: Review

References (53)

1. Huizinga TWJ. Genetics in rheumatology. Best Pract Res Clin Rheumatol 2003; 17:703-716.
2. MacGregor AJ, Snieder H, Rigby AS, et al. Characterising the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43:31-37.
3. Osorio Y, Fortea J, Bukulmez H, et al. Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum 2004; 50:2757-2765. This is the first publication to provide convincing statistical evidence of the expected number of RA linkage peaks.
4. John S, Shephard N, Liu G, et al. Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am J Hum Genet 2004; 75:54-64. This is the first use of an array-based SNP typing facility in comparison with conventional microsatellite typing. Moreover fine mapping of HLA class II genes in the linkage peak is performed.
5. Suzuki A, Yamada R, Chang X, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003; 34:395-402.
6. Caponi L, Petit-Teixeira E, Sebbag M, et al. A family-based study shows no association between rheumatoid arthritis and the PADI4 gene in a French Caucasian population. Ann Rheum Dis 2004 Oct 14 [Epub ahead of print].
7. Barton A, Bowes J, Eyre S, et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 2004; 50:1117-1121.
8. Hoppe B, Heymann GA, Tolou F, et al. A High variability of peptidylarginine deiminase 4 (PADI4) in a healthy white population: characterization of six new variants of PADI4 exons 2-4 by a novel haplotype-specific sequencing-based approach. J Mol Med 2004; 82:762-767.
9. Barton A, John S, Ollier WE, et al. Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians. Arthritis Rheum 2001; 44:61-65.
10. Dieude P, Petit E, Cailleau-Moindrault S, et al. Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity. Arthritis Rheum 2002; 46:2039-2044.
11. Van der Helm-van Mil AH, Dieude P, Schonkeren JJ, et al. No association between tumour necrosis factor receptor type 2 gene polymorphism and rheumatoid arthritis severity: a comparison of the extremes of phenotypes. Rheumatol 2004; 43:1232-1234. This paper exploits the richness of the phenotype data in inception cohorts in RA by using an extreme of the phenotype approach.
12. MacGregor A, Ollier W, Thomson W, et al. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol 1995; 22:1032-1036.
13. Moreno I, Valenzuela A, Garcia A, et al. Association of the shared epitope with radiological severity of rheumatoid arthritis. J Rheumatol 1996; 23:6-9.
14. Kaltenhäuser S, Wagner U, Schuster E, et al. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity. J Rheumatol 2001; 28:735-744.
15. De Vries N, Tijssen H, van Riel PL, et al. Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at position 67-74 of the HLA-DRB1 molecule. Arthritis Rheum 2002; 46:921-928.
16. Wilkens RF, Nepom GT, Marks CR, et al. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians: further evidence for the 'shared epitope' hypothesis. Arthritis Rheum 1991; 34:43-47.
17. Ollier WE, Stephens C, Awad J, et al. Is rheumatoid arthritis in Indians associated with HLA antigens sharing a DR beta 1 epitope? Ann Rheum Dis 1991; 50:295-297.
18. Ollier W, Thomson W. Population genetics of rheumatoid arthritis. Rheum Dis Clin North Am 1992; 18:741-759.
19. Gorman JD, Lum RF, Chen JJ, et al. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum 2004; 50:400-412.
20. Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992; 89:2033-2039.
21. Gorman JD, David-Vaudey E, Pai M, et al. Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum 2004; 50:3476-3484.
22. d transgene on collagen induced arthritis. J Exp Med 1994; 180:1559-1564.
23. Zanelli E, Gonzalez-Gay MA, David CS. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today 1995; 16:274-278.
24. Van der Horst-Bruinsma IE, Visser J, Hazes JM, et al. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol 1999; 60:152-158.
25. Vos K, Van der Horst-Bruinsma IE, Hazes JMW, et al. Evidence for a protective role of the human leucocyte antigen class II region in early rheumatoid arthritis. Rheumatol 2001; 40:133-139.
26. Seidl C, Körbizer J, Badenhoop K, et al. Protection against severe disease is conferred by DERAA-bearing HLA-DRB1 alleles among HLA-DQ3 and HLA-DQ5 positive rheumatoid arthritis patients. Hum Immunol 2001; 62:523-529.
27. Vos K, Visser H, Schreuder GMTh, et al. Human leucocyte antigen-DQ and DR polymorphism predict rheumatoid arthritis outcome better than DR alone. Hum Immunol 2001; 62:1217-1225.
28. Wagner U, Kaltenhäuser S, Pierer M, et al. Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis. Rheumatol 2003; 42:553-562.
29. Lee JK, Park C, Kimm K, et al. Genome-wide multilocus analysis for immune-mediated complex diseases. Biochem Biophys Res Commun 2002; 295:771-773.
30. Tokuhiro S, Yamada R, Chang X, et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003; 35:341-348.
31. Begovich AB, Carlton VE, Honigberg LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75:330-337. This is a nice example of a genome-wide association study using SNPs. The excellent methodology used multiple rounds of replication to diminish the chance of false-positive results. A new genetic risk factor for RA was identified.
32. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36:337-338. Replication of a new RA risk gene in another autoimmune disease is reported.
33. Huizinga TW, Pisetsky DS, Kimberly RP. Associations, populations, and the truth: recommendations for genetic association studies in arthritis and rheumatism. Arthritis Rheum 2004; 50:2066-2071. This article gives guidelines for genetic association studies as well as the evidence for these guidelines.
34. Collado L, Rueda B, Caliz R, et al. Lack of association between the I kappa BL promoter polymorphism and rheumatoid arthritis. Arthritis Rheum 2004; 50:2032-2033. This is a nice study using two cohorts to replicate lack of association.
35. Eskdale J, McNicholl J, Wordsworth P, et al. Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 1998; 352:1282-1283.
36. Lard LR, Van Gaalen F, Schonkeren J, et al. The -A2849G II10 promoter polymorphism is associated with autoantibody production and joint destruction in RA. Arthritis Rheum 2003; 48:1841-1848.
37. Lin MT, Storer B, Martin PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349:2201-2210.
38. Kurreeman FA, Schonkeren JJ, Heijmans BT, et al. Transcription of the IL10 gene reveals allele specific regulation at the mRNA level. Hum Mol Genet 2004; 13:1755-1762. This is the first study to unequivocally demonstrate that IL10 haplotypes can be transcribed at a different rate, thereby providing sound evidence for the observed disease association.
39. Padyukov L, Hytonen AM, Smolnikova M, et al. Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J Rheumatol 2004; 31:422-425.
40. Schotte H, Schluter B, Drynda S, et al. Interleukin-10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis. Ann Rheum Dis 2004 Sep 2 [Epub ahead of print].
41. Prokunina L, Padyukov L, Bennet A, et al. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum 2004; 50:1770-1773.
42. Barton A, Jury F, Eyre S, et al. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum 2004; 50:748-752.
43. Xu B, Arlehag L, Rantapaa Dahlqvist S, et al. Beta-adrenergic receptor gene SNPs are associated with rheumatoid arthritis in Northern Sweden. Ann Rheum Dis 2004 Oct 21 [Epub ahead of print].
44. Wu H, Khanna D, Park G, et al. Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort. Arthritis Rheum 2004; 50:3093-3103.
45. Lee EB, Kim JY, Kim EH, et al. Intercellular adhesion molecule-1 polymorphisms in Korean patients with rheumatoid arthritis. Tissue Antigens 2004; 64:473-477.
46. Pokorny V, McQueen F, Yeoman S, et al. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann Rheum Dis 2005; 64:487-490.
47. Han SW, Kim GW, Seo JS, et al. VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatol 2004; 43:1173-1177.
48. Barton A, Platt H, Salway F, et al. Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid or inflammatory polyarthritis. J Rheumatol 2004; 31:442-447.
49. Lee YH, Kim HJ, Rho YH, et al. Interleukin-1 receptor antagonist gene polymorphism and rheumatoid arthritis. Rheumatol Int 2004; 24:133-136.
50. Sanchez E, Orozco G, Lopez-Nevot MA, et al. Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004; 63:54-57.
51. Padyukov L, Silva C, Stolt P, et al. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004; 50:3085-3092. This is the first demonstration of an interaction between an environmental risk factor and a genetic risk factor in RA.
52. Van Gaalen FA, van Aken J, Huizinga TW, et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004; 50:2113-2121. This study demonstrated that the major genetic risk factor for RA specifically confers risk for the presence of anti-CCP antibodies.
53. Hill JA, Southwood S, Sette A, et al. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003; 171:538-541.